Associated Papers
Accurate affinity models for SH2 domains from peptide binding assays and free-energy regression.
Gagoski D et al.
Protein Science : a Publication of the Protein Society, 2025
41088778 (PubMed )
Supplement: PRO-34-e70317-s008.xlsx › _S6_-_PTMVar_-_Grb2
RHOA-associated disorder can be non-mosaic.
Nakato D et al.
European Journal of Medical Genetics, 2025
From Clinical Observation to Genetic Confirmation: Somatic Mosaic Mutations in RHOA on Ectodermal Dysplasia With Multi-System Involvement.
Durmusalioglu EA et al.
American Journal of Medical Genetics. Part A, 2025
Accurate sequence-to-affinity models for SH2 domains from multi-round peptide binding assays coupled with free-energy regression.
Gagoski D et al.
Biorxiv : the Preprint Server for Biology, 2025
39764007 (PubMed )
Supplement: media-1.xlsx › _S6_-_PTMVar_-_Grb2
A novel pathogenic RHOA variant in a patient with patterned cutaneous hypopigmentation associated with extracutaneous findings.
Cai ZR et al.
Pediatric Dermatology, 2022
Next-generation sequencing approaches and challenges in the diagnosis of developmental anomalies and intellectual disability.
Bruel AL et al.
Clinical Genetics, 2020
Postzygotic inactivating mutations of RHOA cause a mosaic neuroectodermal syndrome.
Vabres P et al.
Nature Genetics, 2019
Gastric poorly cohesive carcinoma: a correlative study of mutational signatures and prognostic significance based on histopathological subtypes.
Kwon CH et al.
Histopathology, 2018
Select a paper to view details